As the contribution of homologous recombination is crucial for protecting tumor cells against DNA damage induced by agents such as TMZ, our finding that the HR-regulating factor FEN1 enhances DNA-PKcs-deficient glioma cell viability by playing a major role in DNA replication progression and the DNA damage response is important. This evidence concerns the gene FEN1 and central nervous system cancer.